Liquidia Technologies to Develop Ophthalmology-Focused Company

Research Triangle Park, N.J.-based biotechnology company Liquidia Technologies has announced plans to form an ophthalmology-focused company in response to recent success with products in the therapeutics area.  

Advertisement
Carrie Pallardy

Liquidia intends to release more information on the new company in the second quarter of 2013. The company’s premier product will be designed to treat glaucoma and is expected to enter clinical trials in 2014.

More Articles on Ophthalmology:
La Peer Health Systems Recruits Dr. Aaron Savar
InSite Vision to Present at ARVO 2013
Study Finds 65% of Liver Transplant Patients Develop AMD

The hidden revenue loss hospitals rarely see until it’s too late

Recommended Whitepaper

Advertisement

Next Up in Ophthalmology

  • Montana physician practice acquired 

    Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

    By: Patsy Newitt

  • Louisiana ophthalmology practice acquired 

    Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

    By: Patsy Newitt
Advertisement

Comments are closed.